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Phencyclidine (PCP) is a dissociative anesthetic agent which blocks the excitatory effect of N-methyl-D-aspartate 
(NMDA) in the central nervous system. To investigate the role of the PCP reactive site in the control of NMDA activation 
of hippocampal pyramidal cells, we have examined the action of PCP and some of its analogues on the response proper- 
ties of single NMDA receptors. Application of NMDA (5-15 PM) to outside-out patches of membrane elicited bursts 
of ion channel openings which were greatly reduced in frequency and duration in the presence of PCP (2.5-10 PM) or 
m-amino-PCP (2.5-10 PM), a behaviorally active derivative of PCP. These effects of PCP were reversed when the mem- 
brane potential was shifted from negative to positive values. Application of the behaviorally inactive agent I-piperidino- 
cyclohexanccarbonitrile (2 220 PM) left NMDA-activated currents relatively unaltered. Treatment with another analo- 
gue, m-nitro-PCP (5-20 PM), resulted in an unexpected increase in frequency of openings. At a higher concentration 
(10&300 ,uM), however, m-nitro-PCP acted like PCP in reducing frequency of opening and channel life-time. Like PCP, 
these effects of m-nitro-PCP were reversed at positive potentials. Taken together, these results suggest that PCP and its 
derivatives block the open state of the NMDA channel. Moreover, the dual effect of m-nitro-PCP shows that excitability 
is not necessarily decreased by PCP analogues but may instead be enhanced depending on modifications of the PCP 
molecule. 
Single channel current; Patch clamp technique; Hippocampal culture; Psychotropic agent 
1. INTRODUCTION 
The psychotropic agent PCP has been shown to 
cause hallucinations and visual disturbances, 
enhanced locomotor activity, disorientation, anx- 
iety, and dissociative anesthesia [l-3]. In view of 
these extensive effects, the question arises as to 
what mechanisms PCP affects in the central ner- 
vous system (CNS). Several hypotheses have been 
proposed to explain some of the psychopathologi- 
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cal effects induced by PCP. Initially, it was 
suggested that the effects of PCP are due to a 
blockade of potassium channels and release of a 
variety of neurotransmitters, such as dopamine. 
Evidence for this hypothesis has been provided by 
reports that PCP binds to and blocks potassium 
channels in the rat CNS while its behaviorally inac- 
tive analogues do not [4-91. However, other 
reports have suggested that the effects of PCP are 
also related to a blockade of NMDA receptors 
[lo-131. In the light of such an effect, we have ex- 
a’mined the molecular mechanism subserving the 
action of PCP by direct inspection of its effects on 
single ion channel currents evoked by NMDA. We 
were especially interested in the examination of the 
effects of PCP on frequency and duration of 
bursts. Outside-out patches of membrane were 
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isolated from neonatal rat hippocampal neurons 
kept in culture and the NMDA-induced openings 
were resolved using patch clamp techniques [14]. 
To correlate the effects of PCP on these currents 
with the behavioral events, we compared effects of 
behaviorally active and inactive analogues of PCP 
[15,16]. It was found that both behaviorally active 
and some of the inactive analogues of PCP affect 
the kinetic properties of the NMDA-induced 
openings. 
3. RESULTS 
3.1. Effects of PCP, PCC and m-amino-PCP on 
the NMDA-evoked channel activity 
Application of NMDA (1.5-250 PM) to the ex- 
ternal solution resulted in channel openings of con- 
ductance states and properties similar to those 
previously described in the hippocampus [18] and 
cerebellum [24]. Samples of the single channel cur- 
rents recorded during application of NMDA, and 
2. MATERIALS AND METHODS NMDA 5 phi 
2.1. Culture methods 
Hippocampal neurons were obtained from Sprague-Dawley 
rats (Zivic-Miller) 2-7 days after birth. These neurons were 
selected for study due to their high density of PCP binding sites 
[17] and because the effects of NMDA on single ion currents 
have been described in the hippocampus [18]. The methods for 
tissue culture of neurons have been described elsewhere 
[19-221. 
NMDA 5 FM 
I’CC Ill #LM 
2.2. Patch-clamp experiments 
Electrophysiological recordings were made using patch clamp 
techniques [ 14,231. Single channel currents were studied on 43 
outside-out patches of membrane excised from hippocampal 
neurons. Solutions consisted of (in mM): 165 NaCl, 5 KCI, 2 
CaCl2, 10 glucose and 5 Hepes for the solution bathing the cells 
(external solution), and 80 CsClz, 80 CsF, 10 CsEGTA, 10 
Hepes for the solution inside the electrode (internal solution). 
The pH of the external solution was adjusted to 7.3 and the 
osmolarity to 310 mosM while the pH of the internal solution 
was kept at 7.25 and its osmolarity at 320 mosM. The PCP 
analogues used in these experiments were obtained from the Na- 
tional Institute of Drug Abuse (Rockville, MD). 
NMl)A 5 PM 
PCI 5 pM 
An LM-EPC-7 patch clamp system (List Electronic, FRG) 
was used to record single channel currents from outside-out 
patches of membrane dissociated from pyramidal-shaped hip- 
pocampal neurons grown 7-14 days in culture. Pharmacologi- 
cal agents were applied to the external solution only after 
recording activity for l-2 min to ensure that spontaneous 
openings of ion channels were not present. Each membrane 
patch was usually studied for over 30 min and up to 2 h. In 
many cases, different pharmacological agents, applied at 
several concentrations, were tested in the same patch; their ef- 
fects were reversed after removing PCP and analogues by gentle 
perfusion with drug-free solution. 
NMI)A 5 ,,M 
IVY 10 ,,M 
NMDA 8 +h4 
Single channel recordings were filtered at 3 kHz (Bessel, 
- 3 db), stored on FM magnetic tape (Racal4DS), and digitized 
at 12.5 kHz. Amplitude, duration and frequency of single chan- 
nel currents were determined using the IPROC-2 program [23] 
run on an IBM-AT microcomputer. Open times are the dura- 
tions of valid events that exceed a threshold level of 50% of the 
single channel amplitude estimate. Since the NMDA-activated 
openings contain flickers, burst durations are also given - a 
burst being defined here as any individual open event or series 
of open events and brief (< 5 ms) closed events, separated from 
neighboring events by >5 ms. 
Fig. 1. Single channel currents recorded on an outside-out patch 
of membrane are shown in the sequential order of testing (from 
top to bottom) and represent responses to NMDA (5 pM), 
NMDA (5 PM) plus PCC (10 PM), NMDA (5 PM) plus PCC 
(20 FM), NMDA (5 PM) plus PCC (100 PM), NMDA (5 ,uM) 
plus PCP (5 pM), NMDA (5 FM) plus PCP (1OgM) and, 
finally, responses to NMDA (5 PM) alone approx. 40 min after 
perfusion with drug-free solution. While PCC had no 
discernible effects on the frequency of channel openings or 
duration of the bursts, PCP markedly decreased frequency of 
channel openings and burst time. 
157 
Volume 235, number 1,2 FEBS LETTERS August 1988 
the effects of PCP and of its behaviorally inactive 
analogue PCC on these currents are illustrated in 
fig.1. As expected, the major component of the 
NMDA response consisted of high-conductance 
(approx. 40 pS) channel openings of variable dura- 
tion which appeared either singly or in bursts of 
NMDA (5 PM) 
NMDA (5 PM) + PCP (10 PM) 
Membrane Potential, -70 mV 
NMDA (5 PM) + PCP (10 PM) 
-l_- 
Membrane Potential, +60 mV 
< 
n 
0 
50 msec 
Fig.2. Single channel currents recorded at -70 mV in the 
presence of NMDA (5 PM) and at - 70 and 60 mV in the 
presence of NMDA (5 PM) plus PCP (10 PM). 
several openings in rapid succession. These events 
were not significantly affected when PCC was ap- 
plied at concentrations of 10,20, 100 (fig. 1) and up 
to 220 PM (not shown). In contrast, application of 
PCP (5 PM) to the same patch markedly reduced 
the frequency of open events, and also shortened 
the burst duration. The few remaining bursts 
usually consisted of only a single opening. Ap- 
plication of additional PCP (10 FM) led to a nearly 
complete blockade of NMDA-induced openings. 
These effects of PCP were only reversible several 
minutes after superfusion with drug-free solution. 
For instance, as illustrated in fig. 1,40 min were re- 
quired for a partial recovery of the NMDA 
response (shown in the lower 2 traces). The partial 
recovery of channel opening was associated with 
reappearance of the long-duration bursts, i.e. 
bursts that last for over 10 ms. Immediate recovery 
was obtained when the membrane potential was 
shifted from negative to positive values. For in- 
stance, in the example shown in fig.2 the potential 
was changed from - 70 to 60 mV, and the 
NMDA 5 &I 
NMDA 5 pM 
m-Amino-PCP 5 d 
NMDA 5 &I 
m-Amiio-PCP 10 &4 
NMDA 5 ,A4 
Fig.3. Single channel currents recorded in the presence of (from 
top to bottom): NMDA (5 pM), NMDA (5 PM) plus m-amino- 
PCP (5 pM), NMDA (5 PM) plus m-amino-PCP (10 ,uM) and 
NMDA (5 PM) 30 min after wash. 
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NMDA (5 PM) NMDA (5 PM) + m-Nitro-PCF’ (100 a) 
d * 
- w 
NMDA (5 PM) + m-Nitro-PCP (0.5 +M) NMDA (150 PM) + m-Nitro-PCP (100 CM) 
- - 
n * 
NMDA (5 PM) + m-Nitro-PCP (10 CM) NMDA (5 CM) after 5 min wash 
Membrane potential, -70 mV 
/ 
S 
3 
50 msec 
Fig.4. Single channel currents obtained in the presence of (from top to bottom): NMDA (5 ,uM), NMDA (5 ,TM) plus m-nitro-PCP 
(0.5 PM), NMDA (5 FM) plus m-nitro-PCP (IOpM), NMDA (5 ,uM) plus m-nitro-PCP (100 FM), NMDA (150 PM) plus m-nitro-PCP 
(100 PM) and finally NMDA (5 FM) again 5 min after wash. At a concentration of 10 pM, m-nitro-PCP strongly facilitated the NMDA 
response by increasing frequency of openings. In contrast, a blocking effect was present at 100 gM m-nitro-PCP. 
frequency of channel opening and the channel 
lifetime reversed to a condition similar to control. 
3.2. Effects of m-nitro-PCP on the NMDA 
evoked channel activity 
Similar results were obtained with m-amino- In contrast to PCP and m-amino-PCP, the ef- 
PCP, a behaviorally active analogue of PCP. Fig.3 fects obtained with the behaviorally inactive 
shows traces of single channel openings evoked by analogues were more variable: while PCC did not 
NMDA which were markedly reduced in frequency alter the NMDA responses (see above), m-nitro- 
after the application of m-amino-PCP (5 PM). At PCP markedly facilitated the NMDA responses by 
a relatively low concentration, m-amino-PCP increasing the frequency of NMDA-activated 
(5 PM) reduced the number of channel openings openings. As shown in fig.4, single channel open- 
and decreased burst duration (compare these ings occurred at a higher rate in the presence of 
results with the effects of PCP shown in fig. 1). Ad- NMDA (5 ,uM) plus m-nitro-PCP (10 ,uM) than in 
ministration of m-amino-PCP to a final concentra- the presence of NMDA (5 PM) alone. Otherwise, 
tion of 10 PM led to a complete blockade of the kinetic properties of these openings remained 
channel activity. Nevertheless, some recovery of relatively unaffected by m-nitro-PCP and they 
channel function was observed approximately cannot be distinguished from those present under 
30 min after washing the membrane with external control condition. The facilitatory effects induced 
solution free of m-amino-PCP (fig.3). by m-nitro-PCP reached a peak at lOpM, and 
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subsequently decreased at higher concentrations. 
At a concentration of 100 PM m-nitro-PCP, the 
frequency of openings decreased drastically and 
kinetic properties were substantially affected as 
revealed by the appearance of longer intraburst 
closures and the reduced burst durations (fig.3). 
These effects of m-nitro-PCP were quickly re- 
versed upon superfusion with drug-free solution, 
such that control conditions were reached in less 
than 5 min, in contrast to over 30 min in all cases 
when PCP and m-amino-PCP were tested. 
induced events (openings or bursts) as a function 
of event duration, PCP at a concentration of over 
2.5 PM, reduced both the open time and the burst 
duration. Burst duration was particularly affected, 
with most bursts lasting less than 10 ms in the 
presence of PCP. The same figure also shows that 
both the open time and the burst duration were ap- 
parently unaltered by 10 PM m-nitro-PCP. 
4. DISCUSSION 
The effects of PCP and m-nitro-PCP on NMDA The present results demonstrate that the 
responses were not only restricted to the frequency behaviorally active and inactive analogues of PCP 
of openings, but included the duration of the single can be distinguished by their effects on single chan- 
channel currents. To provide a quantitative nel currents evoked by NMDA. Both PCP and its 
analysis of these findings, we have computed the behaviorally active derivative m-amino-PCP at 
duration of NMDA-evoked single channel cur- concentrations of 2-10pM blocked NMDA cur- 
rents. As illustrated in the histograms of fig.5, rents by drastically reducing frequency and dura- 
which plot the normalized number of NMDA- tion of channel openings. In contrast, the 
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Fig.5. Histograms representing number of events plotted as a function of open time duration or burst duration. Recordings were 
conducted in the presence of 5 pM NMDA (control), NMDA (5 ,uM) and PCP (10 pM, upper panels) or NMDA (5 FM) and m-nitro- 
PCP (IOpM, lower panels). Number of events was normalized so that the largest bar is equal to 1.0. Actual number of events was 
between 340 and 1856. Holding potential = -75 mV. 
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behaviorally inactive analogue m-nitro-PCP 
displayed two distinct effects on NMDA openings. 
At low concentration (5-20 PM), m-nitro-PCP 
markedly increased the frequency of NMDA- 
induced openings but had no effect on channel 
lifetime. At a higher concentration (greater or 
equal to 100 PM) m-nitro-PCP reduced both chan- 
nel lifetime and frequency. 
In the light of these effects, the question arises 
whether m-nitro-PCP acts at the binding site for 
PCP. An alternative possibility is that m-nitro- 
PCP acts at the binding site for glycine, which has 
also been reported to facilitate NMDA receptor ac- 
tivity [25]. The answer to this question may be ob- 
tained by a comparison of the effects of these 
agents on the kinetic properties of the NMDA 
openings. For instance, in contrast to m-nitro- 
PCP, glycine has been reported to increase channel 
lifetime [25]. Moreover, we have observed that 
glycine even at high concentration (up to 100 PM) 
did not reduce channel lifetime or frequency, as 
occurred with m-nitro-PCP (see fig.2 and Ramoa 
et al., in preparation). Therefore, it seems unlikely 
that m-nitro-PCP and glycine bind at a similar site. 
On the other hand, the effects of m-nitro-PCP ad- 
ministered at a high concentration are similar to 
those elicited by PCP. In addition, the blocking ef- 
fects of PCP and m-nitro-PCP were relieved at a 
positive potential (Ramoa et al., in preparation), 
thus suggesting that both agents interact within the 
ionic channel component of the NMDA receptor. 
Such a reversal of PCP effects at positive poten- 
tials was also observed at the nicotinic 
acetylcholine receptor (AChR) ion channel at the 
neuromuscular junction [26], where actions of 
PCP on both closed and open conformations of 
the AChR were reported. The present results lend 
support to the notion that PCP affects the open 
conformation of the NMDA receptor. However, 
and additional action of PCP on the closed chan- 
nel state, as suggested for the nicotinic AChR [26], 
cannot be ruled out. 
These findings have implications for understan- 
ding the functional organization of the NMDA 
receptor. It is generally thought that PCP blocks 
ion currents from flowing by binding inside the 
open channel macromolecule and impeding the 
transmembrane ion fluxes [27-291. It is unclear, 
however, whether PCP regulates channel perme- 
ability by allosteric mechanisms or by occluding 
the channel and preventing ionic conductance 
[27-311. However, an open-channel model in 
which the presence of the ligand molecule within 
the channel creates a physical impediment to the 
ion fluxes cannot readily explain the facilitatory ef- 
fects observed with application of m-nitro-PCP. 
Instead this agent, which differs from PCP by a 
nitro group, may bind inside the ion channel and 
lead to enhancement of activity through a confor- 
mational modification of the NMDA receptor-ion 
channel complex. Perhaps, m-nitro-PCP can in- 
crease the affinity of the receptor macromolecule 
to NMDA. 
The results obtained with PCP and its analogues 
help us to understand not only the functional 
modulation of the NMDA receptor but also how 
changes in this modulation may contribute to 
behavioral effects. The correlation found here be- 
tween the blockade of NMDA response and the 
behavioral effects of PCP analogues is consistent 
with the notion that interference with the function 
of the NMDA receptor contributes to some of the 
behavioral disturbances observed with PCP. 
Nevertheless, the correlation between blockade of 
NMDA receptors and the central effects of PCP 
should be interpreted with great caution. It may be 
difficult to explain the wide spectrum of effects of 
PCP, which in humans ranges from perceptual 
disturbances to dissociative anesthesia [2], by a 
single underlying electrophysiological mechanism. 
It is more likely that PCP alters synaptic transmis- 
sion mediated by a variety of neurotransmitter 
systems. PCP has been shown to interact with 
nicotinic and muscarinic receptors [32,33] and to 
block potassium channels [4-91. Furthermore, as 
previously suggested [4,6,9], the blockade of 
presynaptic potassium channels could lead to an 
increased release of several neurotransmitters, in- 
cluding excitatory amino acids (which can still ac- 
tivate the kainate and quisqualate receptors in the 
presence of PCP [lo]). Thus, an increased release 
of synaptic transmitters combined with the an- 
tagonism of a variety of post-synaptic receptors 
may provide the substrate for most of the effects 
of PCP. 
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